loading . . . Long Covid: Unlocking the Keys To Recovery For the NSU Lunch and Learn series, Dr. Nancy Klimas presents "Long COVID: Unlocking the Keys to Recovery," where she examines the mechanisms, risk factors, and current treatment strategies for long COVID, and introduces an active clinical trial investigating spike protein persistence as a potential root cause of the condition. Dr. Klimas provides a clinical overview of the most common long COVID symptoms — including post-exertional malaise, brain fog, autonomic dysfunction, and non-restorative sleep — and draws on her decades of experience treating ME/CFS and Gulf War illness to contextualize long COVID within the broader landscape of post-viral illness. She discusses key hypotheses driving current research, including viral persistence, chronic immune activation, mitochondrial dysfunction, and the gut-brain axis. She also presents findings on spike protein detection and its correlation with symptom severity, endothelial dysfunction, and neuroinflammation, before describing the Institute's ongoing monoclonal antibody clinical trial — using an AstraZeneca long-acting antibody product to neutralize residual spike protein — as well as the team's multidisciplinary clinical approach to managing the condition. Key points: 00:00 Introduction and welcome 05:05 Overview of the Institute for Neuro-Immune Medicine 06:06 Long COVID: still ongoing, not behind us 06:38 Fatigue, PEM, neurological, cardiovascular, autonomic 08:05 POTS and autonomic dysfunction explained 09:08 Viral persistence, immune activation, mitochondria, gut-brain axis 11:22 Who gets long COVID? 13:40 Variants and reinfection risk 14:21 CDC longitudinal study and deep phenotyping 16:01 The monoclonal antibody clinical trial 17:47 Evidence for persistence and links to symptom severity 20:09 Antibody response patterns in long COVID 21:36 AstraZeneca long-acting monoclonal antibody 24:03 Biomarkers, biorepository, and exploratory endpoints 25:02 INIM's multidisciplinary clinical team and treatment targets 27:32 NIH RECOVER, Schmidt Initiative, Florida Department of Health 29:09 Optimism for treatment 31:52 Brain fog — pathophysiology and clinical management 34:18 Perfusion, microthrombi, and endothelial repair 35:38 Spike protein test (SIMOA) and availability 37:02 Long COVID in children and PANDAS 38:58 Why do some people recover and others don't? 40:40 Finding a long COVID provider 43:29 IBS and inflammatory bowel disease in long COVID 44:44 Blood cell count changes 45:14 Clinical markers for ME/CFS 45:53 Does Paxlovid reduce long COVID risk? 46:44 Peripheral neuropathy and small fiber neuropathy 48:32 High-profile long COVID cases 49:32 Forehead bone, spike protein deposits, and surgical implants Dr. Nancy Klimas, a clinical immunologist by training, is the director of the Institute for Neuro-Immune Medicine, who has allotted her life to helping other people find cures for their complex illnesses that were once considered helpless. She works with her fellow medical experts in researching and analyzing the deeper causes of such diseases, particularly on the neuro-immunity side, to provide the best option suited for every single case or story they handle. LinkedIn: https://www.linkedin.com/in/nancy-klimas-49255178/ Instagram: https://instagram.com/nancyklimas Twitter: https://x.com/ngklimas?s=20 Learn more about the Institute for Neuro-Immune Medicine here. Website: https://www.nova.edu/nim/ Facebook: https://www.facebook.com/InstituteForNeuroImmuneMedicine Instagram: https://www.instagram.com/NSU_INIM/ Twitter: https://www.twitter.com/NSU_INIM The Schmidt Initiative for Long Covid: https://silc.org/news/clinical-trial-underway-for-potential-long-covid-treatment/ ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT07021794?cond=Long%20COVID%20&term=Monoclonal%20Antibody&intr=sipavibart&viewType=Card&rank=1 If you'd like to sign up for the study, please complete our REDCap survey: https://redcap.link/NSULongCOVID . To learn more, please contact [email protected] or 954-262-2286 #LongCOVID #MECFS #PostViralIllness #ChronicIllness https://tinyurl.com/4z3pwnr6